Dr Olivia Dean

STAFF PROFILE

Position

Senior Research Fellow

Faculty

Faculty of Health

Department

School of Medicine

Campus

Barwon Health

Contact

o.dean@deakin.edu.au
+61342153300

Publications

Filter by

2016

A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis

Justin Davis, Harris Eyre, A/Prof Felice Jacka, Dr Seetal Dodd, Dr Olivia Dean, Sarah McEwen, Monojit Debnath, John McGrath, Prof Michael Maes, Paul G Amminger, Patrick D McGorry, Christos Pantelis, Prof Michael Berk

(2016), Vol. 65, pp. 185-194, Neuroscience & biobehavioral reviews, Amsterdam, The Netherlands, C1

journal

Antioxidant treatments for schizophrenia

Pedro Vieira da Silva Magalhaes, Dr Olivia Dean, Ana Cristina Andreazza, Prof Michael Berk, Flavio Kapczinski

(2016), Vol. 2016, pp. 1-93, Cochrane database of systematic reviews, London, Eng., C1

journal

A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder

Dr Olivia Dean, Kylie Gray, Kristi-Ann Villagonzalo, Dr Seetal Dodd, Dr Mohammadreza Mohebbi, Ms Tanya Vick, Prof Bruce Tonge, Prof Michael Berk

(2016), pp. 1-9, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal

N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis

Brisa Fernandes, Dr Olivia Dean, Dr Seetal Dodd, Prof Gin Malhi, Prof Michael Berk

(2016), Vol. 77, pp. 457-466, Journal of clinical psychiatry, Memphis, Tenn., C1

journal
2015

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

Marta Rapado-Castro, Prof Michael Berk, Dr Kamalesh Venugopal, Ashley I Bush, Dr Seetal Dodd, Dr Olivia Dean

(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

journal

Tobacco use in bipolar disorder

Daniel Thomson, Prof Michael Berk, Dr Seetal Dodd, Marta Rapado-Castro, Pernille Ellegaard, Dr Olivia Dean

(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1

journal

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Deepmala Deepmala, John Slattery, Nihit Kumar, Leanna Delhey, Prof Michael Berk, Dr Olivia Dean, Charles Spielholz, Richard Frye

(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

B S Fernandes, J Steiner, H Bernstein, Dr Seetal Dodd, J Pasco, Dr Olivia Dean, P Nardin, C A Goncalves, Prof Michael Berk

(2015), Vol. In press, pp. 1-11, Molecular psychiatry, Houndmills, Hampshire, C1

journal

N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review

Georgina Oliver, Dr Olivia Dean, David A. Camfield, Scott Blair-West, A/Prof Chee Ng, Prof Michael Berk, Dr Jerome Sarris

(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1

journal

N-Acetyl Cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study

Dr Jerome Sarris, David A. Camfield, Dr Olivia Dean, Nathan Dowling, Deidre Smith, Jenifer Murphy, Ranjit Menon, Prof Michael Berk, Scott Blair-West, A/Prof Chee Ng

(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1

journal

Future directions for pharmacotherapies for treatment-resistant bipolar disorder

Dr Seetal Dodd, Dr Olivia Dean, Brisa Fernandes

(2015), Vol. 13, pp. 656-662, Current neuropharmacology, Bussum, The Netherlands, C1

journal

The use of mixed methods in drug discovery: integrating qualitative methods into clinical trials

Prof Michael Berk, Dr Renee Otmar, Dr Olivia Dean, Mrs Lesley Berk, Erin Michalak

(2015), pp. 59-73, Clinical trial design challenges in mood disorders, Amsterdam, The Netherlands, B1

chapter
2014

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications

George Anderson, Prof Michael Berk, Dr Olivia Dean, Dr Steve Moylan, Prof Michael Maes

(2014), Vol. 28, pp. -, CNS Drugs, Aukland, New Zealand, C1

journal

The efficacy of adjunctive N-Acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial

Prof Michael Berk, Dr Olivia Dean, Sue Cotton, Susan Jeavons, Michelle Tanious, Kristy Kohlmann, Karen Hewitt, Kirsteen Moss, Christine Allwang, Ian Schapkaitz, Jenny Robbins, Heidi Cobb, Felicity Ng, Dr Seetal Dodd, Ashley I Bush, Gin S. Mahli

(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1

journal

The glutathione system : a new drug target in neuroimmune disorders

Gerwyn Morris, George Anderson, Dr Olivia Dean, Prof Michael Berk, Piotr Galecki, Marta Martin-Subero, Prof Michael Maes

(2014), Vol. 50, pp. 1059-1084, Molecular Neurobiology, Dordrecht , Germany, C1

journal

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.

Christopher G. Davey, Dr Andrew Chanen, Sue Cotton, Dr Sarah Hetrick, Melissa Kerr, Prof Michael Berk, Dr Olivia Dean, Kally Yuen, Mark Phelan, Aswin Ratheesh, Miriam Schafer, G P Amminger, Alexandra G Parker, Danijela Piskulic, Susy M Harrigan, Andrew Mackinnon, Ben Harrison, Patrick D McGorry

(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1

journal

Post-stroke depression therapy: where are we now?

Seyed Fazel Nabavi, Dr Alyna Turner, Dr Olivia Dean, Antoni Sureda, Sayed Mohammad Nabavi

(2014), Vol. 11, pp. 1-13, Current neurovascular research, Bussum, The Netherlands, C1

journal

The Glutathione System: a new drug target in neuroimmune disorders

Gerwyn Morris, George Anderson, Dr Olivia Dean, Prof Michael Berk, Piotr Galecki, Marta Martin-Subero, Micahel Maes

(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1-1

journal

Oxidative & nitrosative stress in depression: why so much stress?

Dr Steve Moylan, Prof Michael Berk, Dr Olivia Dean, Dr Yuval Samuni, Dr Lana Williams, Dr Adrienne O'Neil, Amie Hayley, Prof Julie Pasco, George Anderson, A/Prof Felice Jacka, Prof Michael Maes

(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal
2013

The chemistry and biological activities of N-acetylcysteine

Dr Yuval Samuni, Sara Goldstein, Dr Olivia Dean, Prof Michael Berk

(2013), Vol. 1830, pp. 4117-4129, Biochim biophys acta, Amsterdam, Netherlands, C1

journal

A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

Pedro Vieira da Silva Magalhaes, Dr Olivia Dean, Ashley I Bush, David L. Copolov, Prof Gin Malhi, Kristy Kohlmann, Susan Jeavons, Ian Schapkaitz, Dr Murray Anderson-Hunt, Prof Michael Berk

(2013), Vol. 47, pp. 564-568, Australian and New Zealand journal of psychiatry, London, England, C1

journal

Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness

Prof Michael Berk, Dr Olivia Dean, Hemmo Drexhage, John J McNeil, Dr Adrienne O'Neil, Christopher G. Davey, M. Maes

(2013), Vol. 11, pp. 1-17, BMC medicine, London, England, C1

journal

Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo

Pritha Das, Michelle Tanious, Kristina Fritz, Dr Seetal Dodd, Dr Olivia Dean, Prof Michael Berk, Prof Gin Malhi

(2013), Vol. 47, pp. 347-354, Australian and New Zealand journal of psychiatry, London, England, C1

journal

The promise of N-acetylcysteine in neuropsychiatry

Prof Michael Berk, Prof Gin Malhi, Dr Laura Gray, Dr Olivia Dean

(2013), Vol. 34, pp. 167-177, Trends in pharmacological sciences, Oxford, England, C1

journal

A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): study protocol

Dr Adrienne O'Neil, Prof Michael Berk, A/Prof Catherine Itsiopoulos, Prof David Castle, Rachelle Opie, Ms Josephine Pizzinga, Dr Laima Brazionis, Ms Allison Hodge, Dr Cathy Mihalopoulos, Dr Mary Lou Chatterton, Dr Olivia Dean, A/Prof Felice Jacka

(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1

journal
2012

Minocycline : therapeutic potential in psychiatry

Dr Olivia Dean, Joao Data-Franco, Dr Frank Giorlando, Prof Michael Berk

(2012), Vol. 26, pp. 391-401, CNS Drugs, Auckland, New Zealand, C1

journal

Maintenance N-acetyl cysteine treatment for bipolar disorder : a double-blind randomised placebo controlled trial

Prof Michael Berk, Dr Olivia Dean, Sue Cotton, Clarissa S. Gama, Flavio Kapczinski, B Fernandes, Kristy Kohlmann, Susan Jeavons, Karen Hewitt, Kirsteen Moss, Christine Allwang, Ian Schapkaitz, Heidi Cobb, Ashley I Bush, Dr Seetal Dodd, Prof Gin Malhi

(2012), Vol. 10, pp. 1-11, BMC medicine, London, England, C1

journal

Adjunctive antioxidants for bipolar disorder

Pedro Vieira da Silva Magalhaes, Dr Olivia Dean, Ana Cristina Andreazza, Prof Michael Berk, Flavio Kapczinski

(2012), pp. 1-11, The Cochrane collaboration, Oxford, England, C1-1

journal

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

Dr Olivia Dean, Ashley I Bush, David L. Copolov, Kristy Kohlmann, Susan Jeavons, Ian Schapkaitz, Dr Murray Anderson-Hunt, Prof Michael Berk

(2012), Vol. 66, pp. 514-517, Psychiatry and clinical neurosciences, Richmond, Vic., C1

journal
2011

Antioxidant treatments for schizophrenia

Pedro Vieira da Silva Magalhaes, Ana Cristina Andreazza, Prof Michael Berk, Flavio Kapczinski, Dr Olivia Dean

(2011), pp. 1-13, Cochrane database of systematic reviews, Oxford, U. K., C1-1

journal

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats : relevance to schizophrenia and bipolar disorder

Dr Olivia Dean, A/Prof Maarten van den Buuse, Prof Michael Berk, David L. Copolov, Christine Mavros, Ashley I Bush

(2011), Vol. 499, pp. 149-153, Neuroscience letters, Clare, Ireland, C1-1

journal

N-acetyl cysteine add-on treatment for bipolar II disorder : a subgroup analysis of a randomised placebo-controlled trial

Pedro Vieira da Silva Magalhaes, Dr Olivia Dean, Ashley I Bush, David L. Copolov, Prof Gin Malhi, Kristy Kohlmann, Susan Jeavons, Ian Schapkaitz, Dr Murray Anderson-Hunt, Prof Michael Berk

(2011), Vol. 129, pp. 317-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal

N-acetylcysteine in psychiatry - current therapeutic evidence and potential mechanisms of action

Dr Olivia Dean, Frank Giordano, Prof Michael Berk

(2011), Vol. 36, pp. 78-86, Journal of psychiatry and neuroscience, Ottowa, Canada, C1-1

journal

Qualitative methods in early-phase drug trials : data and methods from a trial of N-acetylcysteine in schizophrenia

Prof Michael Berk, Ahmed Munib, Dr Olivia Dean, Prof Gin Malhi, Kristy Kohlmann, Ian Schapkaitz, Susan Jeavons, Fiona Katz, Dr Murray Anderson-Hunt, Philippe Conus, Dr Barbara Hanna, Dr Renee Otmar, Felicity Ng, David L. Copolov, Ashley I Bush

(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder.

Pedro Vieira da Silva Magalhaes, Dr Olivia Dean, Ashley I Bush, David L. Copolov, Prof Gin Malhi, Kristy Kohlmann, Susan Jeavons, Ian Schapkaitz, Dr Murray Anderson-Hunt, Prof Michael Berk

(2011), Vol. 23, pp. 87-88, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

Prof Michael Berk, Flavio Kapczinski, Ana Cristina Andreazza, Dr Olivia Dean, Dr Frank Giorlando, M. Maes, Murat Yucel, Clarissa S. Gama, Dr Seetal Dodd, B Dean, Pedro Vieira da Silva Magalhaes, Paul G Amminger, Patrick D McGorry, Prof Gin Malhi

(2011), Vol. 35, pp. 804-817, Neuroscience & biobehavioral reviews, Oxford, England, C1-1

journal

Who’s left? Symptoms of schizophrenia that predict clinical trial dropout

Jason Thompson, Prof Michael Berk, Dr Olivia Dean, Kristy Kohlmann, Susan Jeavons, Ashley I Bush, David L. Copolov

(2011), Vol. 26, pp. 609-613, Human psychopharmacology, West Sussex, England, C1-1

journal

Role of dopamine D3 and serotonin 5-HT1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

Manfred Gerlach, Gerd D. Bartoszyk, Peter Riederer, Dr Olivia Dean, A/Prof Maarten van den Buuse

(2011), Vol. 118, pp. 1733-1742, Journal of neural transmission, Amsterdam, The Netherlands, C1-1

journal
2010

Effects of n-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

Christopher Choy Kwok Ho, Dr Olivia Dean, Prof Michael Berk, Ashley I Bush, A/Prof Maarten van den Buuse

(2010), Vol. 649, pp. 224-228, European journal of pharmacology, Amsterdam, The Netherlands, C1-1

journal

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice

Dr Olivia Dean, Ashley I Bush, Prof Michael Berk, David L. Copolov, A/Prof Maarten van den Buuse

(2010), Vol. 97, pp. 293-300, Pharmacology, biochemistry and behavior, Philadelphia, Pa., C1-1

journal

The validity and internal structure of the bipolar depression rating scale (BDRS): data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder

Prof Michael Berk, Dr Seetal Dodd, Dr Olivia Dean, Kristy Kohlmann, Mrs Lesley Berk, Prof Gin Malhi

(2010), Vol. 22, pp. 237-242, Acta neuropsychiatrica, Oxford, England, C1-1

journal

Oxidative pathways as a drug target for the treatment of autism

Kristi-Ann Villagonzalo, Dr Seetal Dodd, Dr Olivia Dean, Kylie Gray, Prof Bruce Tonge, Prof Michael Berk

(2010), Vol. 14, pp. 1301-1310, Expert opinion on therapeutic targets, London, England, C1-1

journal
2009

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice

Dr Olivia Dean, Ashley I Bush, Prof Michael Berk, David L. Copolov, A/Prof Maarten van den Buuse

(2009), Vol. 198, pp. 258-262, Behavioural brain research, Amsterdam, The Netherlands, C1-1

journal

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

Dr Olivia Dean, A/Prof Maarten van den Buuse, Ashley I Bush, David L. Copolov, Felicity Ng, Dr Seetal Dodd, Prof Michael Berk

(2009), Vol. 16, pp. 2965-2976, Current medicinal chemistry, Schiphol, The Netherlands, C1-1

journal

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

Prof Michael Berk, Susan Jeavons, Dr Olivia Dean, Dr Seetal Dodd, Karen M. Moss, Clarissa S. Gama, Prof Gin Malhi

(2009), Vol. 14, pp. 357-360, CNS spectrums, New York, N.Y., C1-1

journal

Effects of N-acetylcysteine on substance use in bipolar disorder : a randomized placebo controlled clinical trial

M. Bernardo, Dr Seetal Dodd, Clarissa S. Gama, David L. Copolov, Dr Olivia Dean, Kristy Kohlmann, Susan Jeavons, Ian Schapkaitz, Dr Murray Anderson-Hunt, Ashley I Bush, Prof Michael Berk

(2009), Vol. 21, pp. 239-245, Acta neuropsychiatrica, Oxford, England, C1-1

journal
2008

N-Acetyl cysteine as a glutathione precursor for schizophrenia : a double blind, randomized, placebo-controlled trial

Prof Michael Berk, David L. Copolov, Dr Olivia Dean, Kristy Lu, Sue Jauncey, Ian Schapkaitz, Dr Murray Anderson-Hunt, Fiona Judd, Fiona Katz, Dr Paul Katz, Sean Ording-Jespersen, John Little, Philippe Conus, Michel Cuenod, Kim Q. Do, Ashley I Bush

(2008), Vol. 64, pp. 361-368, Biological psychiatry, Philadelphia, Pa., C1-1

journal

Glutathione : a novel treatment target in psychiatry

Prof Michael Berk, Felicity Ng, Dr Olivia Dean, Dr Seetal Dodd, Ashley I Bush

(2008), Vol. 29, pp. 346-351, Trends in pharmacological sciences, London, England, C1-1

journal

N-acetyl cysteine for depressive symptoms in bipolar disorder - a double blind, randomized, placebo-controlled trial

Prof Michael Berk, David L. Copolov, Dr Olivia Dean, Kristy Lu, Sue Jauncey, Ian Schapkaitz, Dr Murray Anderson-Hunt, Ashley I Bush

(2008), Vol. 64, pp. 468-475, Biological psychiatry, Philadelphia, Pa., C1-1

journal

Oxidative stress in psychiatric disorders : evidence base and therapeutic implications

Felicity Ng, Prof Michael Berk, Dr Olivia Dean, Ashley I Bush

(2008), Vol. 11, pp. 851-876, International journal of neuropsychopharmacology, Cambridge, England, C1-1

journal

N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility

Dr Seetal Dodd, Dr Olivia Dean, David L. Copolov, Prof Gin Malhi, Prof Michael Berk

(2008), Vol. 8, pp. 1955-1962, Expert opinion on biological therapy, London, England, C1-1

journal
2004

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use

Dr Sean Jespersen, Prof Michael Berk, Caren Van Wyk, Dr Olivia Dean, Dr Seetal Dodd, Christopher P Szabo, Dr Catherine Maud

(2004), Vol. 19, pp. 161-164, International clinical psychopharmacology, Philadelphia, Pa., C1-1

journal